Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Groupon Inc. GRPN

Groupon acts as the middleman between consumers and merchants, offering a variety of products and services at discounts via its online store. It offers consumers daily deals (in the form of online vouchers) from local merchants. Groupon also sells products directly to consumers. It generates revenue from the take rate on the purchase and/or usage of the vouchers (40% of total revenue) and from direct sales (60% of total revenue). More than 65% of Groupon's revenue comes from North America.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

FSD Will Proceed with Phase2 of FSD-201 Soon After Clearance

FSD Pharma ready to proceed with Phase 2 clinical trial of...read more

FSD Pharma Files Investigational New Drug Application “IND”

   rate and reply

FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets

   rate and reply

Lucid-MS for Multiple Sclerosis Treatment

  rate and reply

"Julia Levy Award" Recipient David Allan and Dr. John McGraw

   rate and reply

FSD Pharma Inc: Lucid MS Video

FSD Pharma is delighted to announce pre-clinical findings...read more

FSD: Cancellation of Certain Shares Issued to Former CEO

FSD Pharma Announces Cancellation of Certain Shares Issued to Former Chief Executive Officer Dr. Raza Bokhari   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA...read more

FSD Pharma Issues Corporate Updates

FSD Pharma Issues Corporate Updates TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding company dedicated to...read more

iMining: First Hospital Foundation in Decentraland Metaverse

iMining Enters into Agreement for the First-Ever Hospital Foundation to Be Launched in the Decentraland Metaverse   Vancouver, British Columbia--(Newsfile Corp.) - iMining Technologies...read more

FSD Pharma; Recapping 2021 and What to Look Forward in 2022

  rate and reply

FSD Pharma Inc: Lucid MS Video

FSD Pharma is pleased to share pre-clinical data demonstrating the effectiveness of its lead drug candidate, Lucid-MS, in treating Multiple Sclerosis. The unique potential therapeutic value of Lucid...read more

FSD Pharma Announces Share Repurchase Program

FSD Pharma Announces Share Repurchase Program   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”), a life sciences holding...read more

FSD Pharma Establishes New Regulatory Advisory Board

FSD Pharma Establishes New Regulatory Advisory Board with the Appointment of Joga Gobburu, Ph.D., and Mary Melnyk, Ph.D., as Members   Regulatory Advisory Board will oversee the drug development...read more

H.C. Wainwright 2nd Annual Psychedelics Virtual Conference

FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD...read more

FSD Pharma at the H.C. Wainwright 2nd Annual Psychedelics

FSD Pharma to Present at the H.C. Wainwright 2nd Annual Psychedelics Virtual Conference on December 6th   TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD...read more

FSD Pharma: Demonstrating the Positive Effects of Lucid-MS

FSD Pharma Unveils Videos Demonstrating Positive Effects of...read more

📰📣iMining Technologies Launches Concierge Service📢📣📣

↓↓↓↓↓↓↓↓↓↓↓↓↓Click the link for the Full Details of the Article: ↓↓↓↓↓↓↓↓↓↓↓↓↓     BitBit Financial Inc., a wholly owned subsidiary of iMining Technologies Inc., has set-up concierge...read more

🎥📰Anthony Durkacz on Building a Turnaround at FSD Pharma📣

  rate and reply

📰📣Anthony Durkacz on Building a Turnaround at FSD Pharma🎥

  rate and reply

Selling smoke?

Has anyone looked at their balance sheet lately? As of Q2, they have ~$1.1B in assets (which includes ~$250MM in goodwill and intangibles) and ~$1.05B in liabilities. We already know what goodwill is...read more